0000899243-21-021981.txt : 20210604
0000899243-21-021981.hdr.sgml : 20210604
20210604142938
ACCESSION NUMBER: 0000899243-21-021981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brandenberger Ralph
CENTRAL INDEX KEY: 0001853197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 21996003
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-02
0
0001787400
Nkarta, Inc.
NKTX
0001853197
Brandenberger Ralph
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Common Stock
2021-06-02
4
M
0
340
0.41
A
340
D
Common Stock
2021-06-02
4
M
0
405
4.77
A
745
D
Common Stock
2021-06-02
4
M
0
1358
3.89
A
2103
D
Common Stock
2021-06-02
4
M
0
2037
3.89
A
4140
D
Common Stock
2021-06-02
4
S
0
4140
24.50
D
0
D
Stock Option (right to buy)
0.41
2021-06-02
4
M
0
340
0.00
D
2028-07-18
Common Stock
340
8387
D
Stock Option (right to buy)
4.77
2021-06-02
4
M
0
405
0.00
D
2029-05-10
Common Stock
405
10000
D
Stock Option (right to buy)
3.89
2021-06-02
4
M
0
1358
0.00
D
2029-09-05
Common Stock
1358
33500
D
Stock Option (right to buy)
3.89
2021-06-02
4
M
0
2037
0.00
D
2029-09-05
Common Stock
2037
50250
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
The option is vested and exercisable as to 6,498 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.
The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.
Sr. VP, Technical Operations
/s/ Alicia Hager, as Attorney-in-Fact
2021-06-04